DK1104417T3 - Forbedret omeprazolproces og sammensætninger deraf - Google Patents

Forbedret omeprazolproces og sammensætninger deraf

Info

Publication number
DK1104417T3
DK1104417T3 DK99940964T DK99940964T DK1104417T3 DK 1104417 T3 DK1104417 T3 DK 1104417T3 DK 99940964 T DK99940964 T DK 99940964T DK 99940964 T DK99940964 T DK 99940964T DK 1104417 T3 DK1104417 T3 DK 1104417T3
Authority
DK
Denmark
Prior art keywords
seeding
compositions
omeprazole
aqueous
residual
Prior art date
Application number
DK99940964T
Other languages
Danish (da)
English (en)
Inventor
Nick Anousis
Benjamin Newton Banks
James W Mcmanus
Lingwen Zhou
Hui Liu
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22254872&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1104417(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK1104417T3 publication Critical patent/DK1104417T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK99940964T 1998-08-11 1999-08-06 Forbedret omeprazolproces og sammensætninger deraf DK1104417T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9603798P 1998-08-11 1998-08-11
PCT/US1999/017970 WO2000009497A1 (en) 1998-08-11 1999-08-06 Improved omeprazole process and compositions thereof

Publications (1)

Publication Number Publication Date
DK1104417T3 true DK1104417T3 (da) 2007-07-16

Family

ID=22254872

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99940964T DK1104417T3 (da) 1998-08-11 1999-08-06 Forbedret omeprazolproces og sammensætninger deraf

Country Status (18)

Country Link
US (2) US6166213A (no)
EP (1) EP1104417B1 (no)
JP (1) JP2002522537A (no)
KR (1) KR100632725B1 (no)
CN (1) CN1227246C (no)
AT (1) ATE360626T1 (no)
AU (1) AU764642B2 (no)
BR (1) BR9912883A (no)
CA (1) CA2338967A1 (no)
DE (1) DE69935915T2 (no)
DK (1) DK1104417T3 (no)
ES (1) ES2285857T3 (no)
IL (2) IL141324A0 (no)
NO (1) NO321054B1 (no)
NZ (1) NZ509798A (no)
PT (1) PT1104417E (no)
WO (1) WO2000009497A1 (no)
ZA (1) ZA200101140B (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6303787B1 (en) * 1998-05-27 2001-10-16 Natco Pharma Limited Intermediates and an improved process for the preparation of Omeprazole employing the said intermediates
IL142703A (en) * 1998-11-10 2006-04-10 Astrazeneca Ab Crystalline form of omeprazole
ES2168043B1 (es) 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
SI20875A (sl) * 2001-04-25 2002-10-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Kristalna oblika omeprazola
DE10140492A1 (de) 2001-08-17 2003-08-14 Gruenenthal Gmbh Hydrate von gegebenenfalls substituierten 2-(2-Pyridinyl)methylthio-1H-benzimidazolen und Verfahren zu ihrer Herstellung
JP2005521662A (ja) * 2002-01-25 2005-07-21 サンタラス インコーポレイティッド プロトンポンプ阻害剤の経粘膜送達
KR100873419B1 (ko) * 2002-06-18 2008-12-11 페어차일드코리아반도체 주식회사 높은 항복 전압, 낮은 온 저항 및 작은 스위칭 손실을갖는 전력용 반도체 소자
EP1837335A1 (en) * 2002-08-21 2007-09-26 Teva Pharmaceutical Industries Ltd A method for the purification of Lansoprazole
JP2006500380A (ja) * 2002-08-21 2006-01-05 テバ ファーマシューティカル インダストリーズ リミティド ランソプラゾールの精製方法
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060024362A1 (en) * 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
ATE443051T1 (de) * 2004-10-11 2009-10-15 Ranbaxy Lab Ltd Verfahren zur herstellung substituierter sulfoxide
US20060210637A1 (en) * 2005-03-17 2006-09-21 Qpharma, Llc Stable tablet dosage forms of proton pump inhibitors
US20070026071A1 (en) * 2005-07-28 2007-02-01 Qpharma, Llc Magnesium salt proton pump inhibitor dosage forms
AU2006299424A1 (en) * 2005-10-06 2007-04-12 Auspex Pharmaceuticals, Inc. Deuterated inhibitors of gastric H+, K+-ATPase with enhanced therapeutic properties
WO2007066202A1 (en) * 2005-12-06 2007-06-14 Inogent Laboratories Private Limited Process for the preparation of 2-(2-pyridylmethyl)-sulfinyl-1h-benzimidazoles
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
US7579476B2 (en) * 2006-02-24 2009-08-25 Praktikatalyst Pharma, Llc Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals
WO2008067037A2 (en) 2006-10-05 2008-06-05 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EP2086543A2 (en) 2006-10-27 2009-08-12 The Curators of the University of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
WO2009137648A1 (en) * 2008-05-09 2009-11-12 Aptapharma, Inc. Multilayer proton pump inhibitor tablets
US20090280173A1 (en) * 2008-05-09 2009-11-12 Ishwar Chauhan Multilayer Omeprazole Tablets
WO2010134099A1 (en) 2009-05-21 2010-11-25 Cadila Healthcare Limited One pot process for preparing omeprazole and related compounds
CN103204841B (zh) * 2013-05-09 2014-06-25 成都天台山制药有限公司 奥美拉唑钠及制备方法
CN104592201A (zh) * 2015-01-13 2015-05-06 江苏中邦制药有限公司 一种奥美拉唑的精制方法
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
CN111635393A (zh) * 2020-06-28 2020-09-08 江苏吴中医药集团有限公司 一种艾司奥美拉唑钠的制备方法
CN112679475B (zh) * 2021-01-14 2022-02-15 四川新迪医药化工有限公司 一种奥美拉唑的制备方法及奥美拉唑
WO2023048508A1 (ko) * 2021-09-23 2023-03-30 국립암센터 오메프라졸 갈변물질을 포함하는 암 예방 또는 치료용 약학적 조성물
CN114209697A (zh) * 2021-12-14 2022-03-22 重庆大学附属三峡医院 一种质子泵抑制剂、制备方法及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPH0643426B2 (ja) * 1986-07-25 1994-06-08 東京田辺製薬株式会社 イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
DK171989B1 (da) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
GB2239453A (en) * 1989-11-27 1991-07-03 Haessle Ab Omeprazole
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
ES2026761A6 (es) * 1990-10-31 1992-05-01 Genesis Para La Investigacion Procedimiento de obtencion del omeprazol.
NZ244301A (en) * 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
TW359614B (en) * 1993-08-31 1999-06-01 Takeda Chemical Industries Ltd Composition containing benzimidazole compounds for rectal administration
WO1996038175A1 (en) * 1995-06-02 1996-12-05 Takeda Chemical Industries, Ltd. Stabilized composition comprising an antiulcerative benzimidazole
SE521100C2 (sv) * 1995-12-15 2003-09-30 Astra Ab Förfarande för framställning av en bensimidazolförening
SK283805B6 (sk) * 1996-09-09 2004-02-03 Slovakofarma, A. S. Spôsob prípravy omeprazolu
AU5982298A (en) * 1997-03-07 1998-09-29 A/S Gea Farmaceutisk Fabrik Process for the preparation of 2-{{(2-pyridinyl)me thyl}sulfinyl}-1h-benzimidazoles and novel compounds of use for such purpos
AU5982198A (en) * 1997-03-07 1998-09-29 A/S Gea Farmaceutisk Fabrik Process for the preparation of 2-{{(2-pyridinyl)me thyl}sulfinyl}-1h-benzimidazoles and novel compounds of use for such purpos

Also Published As

Publication number Publication date
AU5470999A (en) 2000-03-06
KR20010072382A (ko) 2001-07-31
WO2000009497A1 (en) 2000-02-24
US6147103A (en) 2000-11-14
AU764642B2 (en) 2003-08-28
CA2338967A1 (en) 2000-02-24
NO20010677D0 (no) 2001-02-09
DE69935915D1 (de) 2007-06-06
CN1227246C (zh) 2005-11-16
ES2285857T3 (es) 2007-11-16
EP1104417A1 (en) 2001-06-06
ZA200101140B (en) 2002-04-09
US6166213A (en) 2000-12-26
NZ509798A (en) 2003-06-30
ATE360626T1 (de) 2007-05-15
EP1104417B1 (en) 2007-04-25
KR100632725B1 (ko) 2006-10-16
PT1104417E (pt) 2007-06-29
CN1322201A (zh) 2001-11-14
NO20010677L (no) 2001-04-09
JP2002522537A (ja) 2002-07-23
DE69935915T2 (de) 2008-01-10
NO321054B1 (no) 2006-03-06
IL141324A (en) 2007-05-15
BR9912883A (pt) 2001-09-25
IL141324A0 (en) 2002-03-10
EP1104417A4 (en) 2002-12-18

Similar Documents

Publication Publication Date Title
DK1104417T3 (da) Forbedret omeprazolproces og sammensætninger deraf
US5386032A (en) Method of synthesis of 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl-1H-benzimidazole (omeprazole)
US5391752A (en) Process for the preparation of antiulcer agents
KR0123935B1 (ko) 에리트로마이신 a옥심 또는 그의 염의 제조방법
IE61717B1 (en) Production of 2-(2-pyridylmethylsulfinyl)benzimidazole compounds
AU2006242782B2 (en) New process for synthesis of proton pump inhibitors
FR2557111A1 (fr) Nouveaux derives ortho-condenses du pyrrole, leur preparation et les medicaments qui les contiennent
HUP0102523A2 (hu) Javított eljárás 5-metoxi-2-[(4-metoxi-3,5-dimetil-2-piridil)-metil]-szulfinil-1H-benzimidazol előállítására
CA2131648A1 (en) Process of making a benzothiadiazole derivative
JP2583062B2 (ja) 複素環化合物の製造法
US4125711A (en) Process for preparing auranofin
KR910009816B1 (ko) 피리딘 유도체의 제조방법
IL98852A (en) Process for the preparation of sulfinylpristinamycin BII
KR950032214A (ko) 세펨 유도체의 제조방법
JPS55151547A (en) Production of guanidinocapronic ester
JPH0674257B2 (ja) 新規なスルホキシド体およびその製造法
JPH04290894A (ja) Ｃｍｐ−シアル酸アナログ体
JPH01254654A (ja) スルホン酸の誘導体及びその塩
PL144447B1 (en) Method of obtaining auranophine
KR20020074984A (ko) 2-메틸클로라이드 피리딘 유도체 및 이를 이용한벤즈이미다졸 유도체의 제조방법
HU207323B (en) New process for producing nicotinic acid esters of morphine derivatives
JPH0291059A (ja) ７‐置換インドール化合物類の製造法
KR930023361A (ko) 항궤양성 오메프라졸의 n-아실레이트 유도체와 그 제조방법, 및 이를 이용한 오메프라졸의 제조방법